Alpha Tau Medical (https://www.alphatau.com/) focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid cancer tumors. Initially developed at Tel Aviv University, Alpha DaRT was shown to be effective and safe for treating different types of cancer in multiple animal studies. The company is running its first clinical trial in several sites in the EU and is currently commencing clinical trials at over 55 leading cancer centers worldwide.

Biotechnology

Alpha Tau Medical

Uzi Sofer

Avia Berkowitz

Uri Salomon

S. Morry Blumenfeld

Rebecca (Feldman) Becker

Peter Melnyk

Eliran Moshe - אלירן משה

Yona Keisari

Ofer Magen

Yaniv Sagie

Rebecca Becker

Amnon Gat

Ronen Segal

Robert Den

Raphi Levy

Itzhak Kelson

The Directors Team at Alpha Tau Medical is responsible for strategic decision-making, overseeing the company’s research, development, and commercialization activities, and ensuring the successful implementation of clinical trials for Alpha DaRT technology. This team collaborates to guide the company's vision, manage high-level operations, and oversee data strategies to optimize cancer treatment outcomes.

Directors Team

Research and Development

Leadership Team

Engineering and Product Management

Directors Team

About

Team members

Other teams at Alpha Tau Medical

Research and Development

Leadership Team

Engineering and Product Management